XC221 60 mg: Clinical Trials

1 trial of XC221 60 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow XC221 60 mg: new trials by email Literature Review of XC221 60 mg trials Research Report on XC221 60 mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers
XC221 60 mg, XC221 200 mg, Placebo - Influenza, Acute Respiratory Infection
Phase 1CompletedPHARMENTERPRISES LLC322017-05-222018-03-08

Conditions studied

Influenza, Human (1)

Sponsors

PHARMENTERPRISES LLC (1)

Countries

Russia (1)